|
|
|
|
Vol. 58, Issue 3, 633-640, September 2000
Department of Biochemistry, University of Ulsan College of
Medicine, Seoul, Korea (H.J.C, Y.J.J., H.J.K, O.H.); and Biomedical
Brain Research Center, National Institutes of Health, Seoul, Korea
(O.H.)
The underlying cause of the selective death of the nigral dopaminergic
neurons in Parkinson's disease is not fully understood. Tetrahydrobiopterin (BH4) is synthesized exclusively in the
monoaminergic, including dopaminergic, cells and serves as an
endogenous and obligatory cofactor for syntheses of dopamine and nitric
oxide. Because BH4 contributes to the syntheses of these two potential oxidative stressors and also undergoes autoxidation, thereby producing reactive oxygen species, it was possible that BH4 may play a role in
the selective vulnerability of dopaminergic cells. BH4 given extracellularly was cytotoxic to catecholamine cells CATH.a,
SK-N-BE(2)C, and PC12, but not to noncatecholamine cells RBL-2H3,
CCL-64, UMR-106-01, or TGW-nu-1. This was not caused by increased
dopamine or nitric oxide, because inhibition of their syntheses did not
attenuate the damage and BH4 did not raise their cellular levels.
Dihydrobiopterin and biopterin were not toxic, indicating that the
fully reduced form is responsible. The toxicity was caused by
generation of reactive oxygen species, because catalase, superoxide
dismutase, and peroxidase protected the cells from the BH4-induced
demise. Furthermore, thiol agents, such as reduced glutathione,
dithiothreitol,
-mercaptoethanol, and
N-acetylcysteine were highly protective. The BH4
toxicity was initiated extracellularly, because elevation of
intracellular BH4 by sepiapterin did not result in cell damage. BH4 was
spontaneously released from the cells of its synthesis to a large
extent, and the release was not further enhanced by calcium influx.
This BH4-induced cytotoxicity may represent a mechanism by which
selective degeneration of dopaminergic terminals and neurons occur.
This article has been cited by other articles:
![]() |
J. M. Han, Y. J. Lee, S. Y. Lee, E. M. Kim, Y. Moon, H. W. Kim, and O. Hwang Protective Effect of Sulforaphane against Dopaminergic Cell Death J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 249 - 256. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Habecker, M. G. Klein, N. C. Sundgren, W. Li, and W. R. Woodward Developmental Regulation of Neurotransmitter Phenotype through Tetrahydrobiopterin J. Neurosci., November 1, 2002; 22(21): 9445 - 9452. [Abstract] [Full Text] [PDF] |
||||